Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | JNJ-89402638 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on JNJ-89402638, a putative bispecific antibody targeting ENPP3 and CD3 (Nov 2024). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| JNJ-89402638 | JNJ 89402638|JNJ89402638 | CD3 Antibody 119 ENPP3 Antibody 5 | Limited information is currently available on JNJ-89402638, a putative bispecific antibody targeting ENPP3 and CD3 (Nov 2024). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06663319 | Phase I | JNJ-89402638 | A Study of JNJ-89402638 for Metastatic Colorectal Cancer | Recruiting | USA | ESP | 1 |